Generate a tailored SOP for Dr. Inusha Iddawela. Improve your application with a focused, well-structured draft.
Inusha Iddawela has over 15 years of experience in molecular cellular biology, with significant academic and industrial expertise in the pharmaceutical and diagnostic sectors. He graduated with a BSc (Hons) in Medical Biochemistry from the University of Leicester in the UK and obtained his PhD in Oncology from University College London, where his doctoral research focused on the study of DNA damage repair. Following his PhD, Inusha worked as a postdoctoral fellow at University College London and the University of Cambridge, studying mechanisms of oncogenesis. He has also served as a Principal Scientist at GlaxoSmithKline in the UK for six years, where he specialized in antibody engineering and the development of novel biotherapeutic agents. After relocating to Australia, he worked at Minifab, leading the development of highly sensitive microfluidic-based point-of-care diagnostic assays. In 2017, Inusha returned to academia and joined the James Whisstock group at Monash University, focusing on the development of novel antibody formats using phage display technology for structural studies and proof of concept studies in animal models aimed at developing therapeutics for various diseases.
Involved in the development of novel biotherapeutic agents.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.